Should a 67-year-old woman who was successfully treated for hepatitis C several years ago continue monitoring HCV RNA viral load and undergo periodic abdominal imaging?

Post-Treatment Hepatitis C Surveillance

You do NOT need to continue monitoring HCV RNA viral load, but you MUST continue abdominal ultrasound surveillance every 6 months indefinitely if you had advanced fibrosis or cirrhosis before treatment. 1

Viral Load Monitoring: NOT Needed

After achieving sustained virologic response (SVR), routine HCV RNA testing is unnecessary. The key points:

• Confirm SVR once at 12 weeks post-treatment with undetectable HCV RNA 2
• No routine viral load monitoring beyond this point unless you have ongoing risk factors for reinfection (injection drug use, high-risk sexual behavior) or develop unexplained liver dysfunction 1, 2
• Late relapse beyond 12 weeks post-treatment is extremely rare (<1%) with modern direct-acting antivirals 2

The critical question is whether you had advanced fibrosis or cirrhosis BEFORE treatment - this determines your cancer surveillance needs, not your viral load.

Abdominal Imaging: Depends on Pre-Treatment Fibrosis Stage

IF YOU HAD CIRRHOSIS (F4) OR ADVANCED FIBROSIS (F3):

Continue abdominal ultrasound every 6 months indefinitely 1, 3, 2

• HCC risk remains elevated even after viral cure (annual incidence 0.2-2.5%) 3
• This risk persists because years of inflammation and fibrosis created permanent changes that can still lead to cancer 4, 1
• Surveillance should continue regardless of whether your fibrosis has improved post-treatment 5
• Alpha-fetoprotein (AFP) can be added to ultrasound but is optional 1, 2

IF YOU HAD MINIMAL/MODERATE FIBROSIS (F0-F2):

No further surveillance needed 1, 2

Important Caveats

Age considerations: While some cost-effectiveness models suggest stopping surveillance at age 70 for cirrhosis or age 60 for F3 fibrosis 3, this should be individualized based on:

• Your overall health and life expectancy
• Ability to tolerate HCC treatment if detected
• Presence of comorbidities (heart, lung, kidney disease)

Additional risk factors that increase HCC risk post-SVR 3, 6:

• Diabetes
• Obesity/fatty liver
• Ongoing alcohol use
• Male sex
• Older age at treatment

If you don't know your pre-treatment fibrosis stage: You need non-invasive assessment now (FibroScan/elastography or FIB-4 score) to determine if surveillance is needed 2. However, post-treatment measurements may underestimate your original fibrosis stage since liver stiffness can improve after viral clearance 7.

What About Endoscopy for Varices?

If you had cirrhosis:

• Initial endoscopy is required to screen for esophageal varices 2
• If no varices found, repeat in 2-3 years 2
• If still no varices at that point, further endoscopy can potentially stop if you have no other risk factors for progressive liver disease 2

Bottom Line Algorithm

1. Confirm SVR once at 12 weeks post-treatment
2. Determine your pre-treatment fibrosis stage (from old records or current assessment)
3. If F3-F4: Abdominal ultrasound every 6 months forever + initial endoscopy
4. If F0-F2: No further monitoring needed
5. Only recheck HCV RNA if you have ongoing reinfection risk or unexplained liver problems